Funding Opportunities

BD Biosciences

 BD Biosciences Stem Cell Research Grants aim to support the continuing study of embryonic, adult, and induced pluripotent stem cells to improve the understanding of both normal and disease processes.  A total of $100,000 worth of research reagents are awarded annually to 10 scientists. Through the grant program, BD Biosciences supports scientists pursuing innovative ideas in stem cell research, helping to define the next generation of scientific breakthroughs.  The application process is simple.  Just write an abstract (850 words maximum), review and accept the program terms and conditions, complete the online application, and submit.Winter 2014 award cycle applications are due June 30.  Click here for more information                                                                    

Differentiation and Integration of Stem Cells (Embryonic and Induced-Pluripotent) Into Developing or Damaged Tissues (R01)

E-mail: mukhopam@mail.nih.gov

National Institute of Child Health and Human Development (NICHD) invites in vivo studies of stem cells in animal models and in humans (if applicable) to better understand how stem cells function within developing or damaged tissues. The areas of emphasis would include systematically profiling and cataloging changes at genetic and epigenetic levels that take place in stem cells and their microenvironment. The purpose is to gain in-depth knowledge of the mechanisms involved in: progressive differentiation of Embryonic Stem Cells (ESCs) into embryonic lineages, progenitor cells and specialized cell types; adult stem cells/progenitor cells during tissue regeneration and wound healing; and Induced Pluripotent Stem Cells (iPSCs) at the site of injury during stem cell therapy.

Understanding the basic mechanisms and application of knowledge-based approaches would allow researchers to generate iPSCs that are more closely related to the ESCs at both genetic and epigenetic levels.

Furthermore, it is expected that replicating developmental mechanisms would ameliorate the safety concerns associated with incomplete differentiation and improper integration of cells in damaged or diseased tissues during stem cell therapy.  This FOA will use the NIH Research Project (R01) award mechanism.  <S2S>  Click here for more details.

Differentiation and Integration of Stem Cells (Embryonic and Induced-Pluripotent) Into Developing or Damaged Tissues (R21)   

E-mail: mukhopam@mail.nih.gov

National Institute of Child Health and Human Development (NICHD) invites in vivo studies of stem cells in animal models and in humans (if applicable) to better understand how stem cells function within developing or damaged tissues. The areas of emphasis would include systematically profiling and cataloging changes at genetic and epigenetic levels that take place in stem cells and their microenvironment. The purpose is to gain in-depth knowledge of the mechanisms involved in: progressive differentiation of Embryonic Stem Cells (ESCs) into embryonic lineages, progenitor cells and specialized cell types; adult stem cells/progenitor cells during tissue regeneration and wound healing; and Induced Pluripotent Stem Cells (iPSCs) at the site of injury during stem cell therapy. Understanding the basic mechanisms and application of knowledge-based approaches would allow researchers to generate iPSCs that are more closely related to the ESCs at both genetic and epigenetic levels. Furthermore, it is expected that replicating developmental mechanisms would ameliorate the safety concerns associated with incomplete differentiation and improper integration of cells in damaged or diseased tissues during stem cell therapy.  This FOA will use the NIH Exploratory/Developmental (R21) grant mechanism.  <S2S>  Click here for more details.

Improvement of Animal Models for Stem Cell-Based Regenerative Medicine (R01)        

E-mail: oleg.mirochnitchenko@nih.gov

 The sponsors invite applications aimed at characterizing animal stem cells and improving existing, and creating new, animal models for human disease conditions.  The intent of this initiative is to facilitate the use of stem cell-based therapies for regenerative medicine. The initiative focuses on the following areas: 1) comparative analysis of animal and human stem cells to provide information for selection of the most predictive and informative model systems; 2) development of new technologies for stem cell characterization and transplantation; and 3) improvement of animal disease models for stem cell-based therapeutic applications.  This FOA will use the NIH Research Project (R01) award mechanism.  The deadlines for receipt of standard applications under this announcement are: February 5, June 5, and October 5 annually.  This program will expire on May 8, 2016.  Click here for more details.

Improvement of Animal Models for Stem Cell-Based Regenerative Medicine (R21)

 E-mail: oleg.mirochnitchenko@nih.gov                    

The sponsors invite applications aimed at characterizing animal stem cells and improving existing, and creating new, animal models for human disease conditions.  The intent of this initiative is to facilitate the use of stem cell-based therapies for regenerative medicine. The initiative focuses on the following areas: 1) comparative analysis of animal and human stem cells to provide information for selection of the most predictive and informative model systems; 2) development of new technologies for stem cell characterization and transplantation; and 3) improvement of animal disease models for stem cell-based therapeutic applications.  This FOA will use the NIH Exploratory/Developmental (R21) grant mechanism.  The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually.  This program will expire on May 8, 2016.  Click here for more details.

BD Biosciences

BD Biosciences Stem Cell Research Grants aim to support the continuing study of embryonic, adult, and induced pluripotent stem cells to improve the understanding of both normal and disease processes.  A total of $100,000 worth of research reagents are awarded annually to 10 scientists. Through the grant program, BD Biosciences supports scientists pursuing innovative ideas in stem cell research, helping to define the next generation of scientific breakthroughs.  Click here for more details.

Institute for Regenerative Medicine

2012 Pilot Project Program (closed)
The Penn Institute for Regenerative Medicine (IRM) is pleased to announce a call for pilot project proposals in the areas of stem cell research and regenerative medicine.  These proposals must focus on the pursuit of new ideas and technologies that would result in innovations transforming these fields.  The IRM will fund at least four (4) applications beginning in April 1, 2012.  Deadline is February 29, 2012.  Click here for more details.